摘要
[目的]评价吗啉硝唑注射液治疗盆腔炎性疾病的疗效及安全性。[方法]盆腔炎性疾病患者52例依据随机、双盲原则分为两组，观察组静滴吗啉硝唑注射液500mg，每天2次，对照组静滴奥硝唑氯化钠注射液500mg，每天2次，疗程14d。[结果]观察组和对照组临床治愈率分别为96．15％及88．46％，两组相比较差异无显著性（P〉0．05）；不良反应发生率分别为23．08％及50．0％，两组比较差异有显著性（P〈0．05）。[结论]吗啉硝唑注射液治疗盆腔炎性疾病安全有效。
[Objective] To evaluate the efficacy and safety of morinidazole injection for the treatment of pelvic inflammatory disease. [Methods] According to randomized and double-blind principle, 52 patients with pelvic inflammatory disease were divided into two groups. The observation group was given intravenous drip injection of morinidazole 500mg, bid. The control group was given ornidazole sodium chloride injection 590mg bid for 14 days. [Results] Clinical curative rates of observation group and control group were 96.15% and 88.46%, respectively（ P 〉0.05）. The incidence of adverse reactions of observation group and control group were 23. 08% and 50.0%, respectively（ P 〈0.05）. [Conclusion] Morinidazole injection for the treatment of pelvic inflammatory disease is safe and effective.
出处
《医学临床研究》
CAS
2012年第12期2368-2369,共2页
Journal of Clinical Research
